Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)
Hong Kong · Delayed Price · Currency is HKD 6.53
-0.02 (-0.31%)
Last updated: Jan 21, 2026, 10:02 AM HKT
HKG:6922 Market Cap
HKG:6922 has a market cap or net worth of 1.57 billion as of January 21, 2026. Its market cap has decreased by -10.88% in one year.
Market Cap
1.57B
Enterprise Value
1.54B
Revenue
93.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.53
Market Cap Chart
Since December 30, 2022, HKG:6922's market cap has decreased from 4.22B to 1.57B, a decrease of -62.91%. That is a compound annual growth rate of -27.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.57B | -4.80% |
| Dec 31, 2025 | 1.65B | -15.69% |
| Dec 31, 2024 | 1.95B | -56.64% |
| Dec 29, 2023 | 4.50B | 6.57% |
| Dec 30, 2022 | 4.22B | - |
| Dec 30, 2022 | 4.22B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 156.50B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |